213 related articles for article (PubMed ID: 31116585)
1. Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.
Kumar V; Ayasolla K; Jha A; Mishra A; Vashistha H; Lan X; Qayyum M; Chinnapaka S; Purohit R; Mikulak J; Saleem MA; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C209-C225. PubMed ID: 31116585
[TBL] [Abstract][Full Text] [Related]
2. Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.
Mishra A; Ayasolla K; Kumar V; Lan X; Vashistha H; Aslam R; Hussain A; Chowdhary S; Marashi Shoshtari S; Paliwal N; Popik W; Saleem MA; Malhotra A; Meggs LG; Skorecki K; Singhal PC
Am J Physiol Renal Physiol; 2018 May; 314(5):F832-F843. PubMed ID: 29357419
[TBL] [Abstract][Full Text] [Related]
3. Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.
Kumar V; Paliwal N; Ayasolla K; Vashistha H; Jha A; Chandel N; Chowdhary S; Saleem MA; Malhotra A; Chander PN; Skorecki K; Singhal PC
Sci Rep; 2019 Mar; 9(1):3582. PubMed ID: 30837512
[TBL] [Abstract][Full Text] [Related]
4. MiR193a Modulation and Podocyte Phenotype.
Jha A; Saha S; Ayasolla K; Vashistha H; Malhotra A; Skorecki K; Singhal PC
Cells; 2020 Apr; 9(4):. PubMed ID: 32316697
[TBL] [Abstract][Full Text] [Related]
5. Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.
Kumar V; Vashistha H; Lan X; Chandel N; Ayasolla K; Shoshtari SSM; Aslam R; Paliwal N; Abbruscato F; Mikulak J; Popik W; Atta MG; Chander PN; Malhotra A; Meyer-Schwesinger C; Skorecki K; Singhal PC
Am J Pathol; 2018 Nov; 188(11):2508-2528. PubMed ID: 30201495
[TBL] [Abstract][Full Text] [Related]
6. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.
Ekulu PM; Adebayo OC; Decuypere JP; Bellucci L; Elmonem MA; Nkoy AB; Mekahli D; Bussolati B; van den Heuvel LP; Arcolino FO; Levtchenko EN
Cells; 2021 Jul; 10(8):. PubMed ID: 34440683
[TBL] [Abstract][Full Text] [Related]
7. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
8. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
10. Effect of
Haque S; Patil G; Mishra A; Lan X; Popik W; Malhotra A; Skorecki K; Singhal PC
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28385815
[TBL] [Abstract][Full Text] [Related]
11. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
[TBL] [Abstract][Full Text] [Related]
12. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
13. APOL1 polymorphism modulates sphingolipid profile of human podocytes.
Valsecchi M; Cazzetta V; Oriolo F; Lan X; Piazza R; Saleem MA; Singhal PC; Mavilio D; Mikulak J; Aureli M
Glycoconj J; 2020 Dec; 37(6):729-744. PubMed ID: 32915357
[TBL] [Abstract][Full Text] [Related]
14. Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.
Jha A; Kumar V; Haque S; Ayasolla K; Saha S; Lan X; Malhotra A; Saleem MA; Skorecki K; Singhal PC
FEBS J; 2020 May; 287(10):2000-2022. PubMed ID: 31714001
[TBL] [Abstract][Full Text] [Related]
15. APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway.
Zhu JY; Lee JG; Fu Y; van de Leemput J; Ray PE; Han Z
Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 37969018
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.
Gupta N; Waas B; Austin D; De Mazière AM; Kujala P; Stockwell AD; Li T; Yaspan BL; Klumperman J; Scales SJ
Sci Rep; 2024 Feb; 14(1):3765. PubMed ID: 38355600
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.
Lan X; Wen H; Saleem MA; Mikulak J; Malhotra A; Skorecki K; Singhal PC
Exp Mol Pathol; 2015 Jun; 98(3):491-501. PubMed ID: 25796344
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
[TBL] [Abstract][Full Text] [Related]
20. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?
Olabisi O; Al-Romaih K; Henderson J; Tomar R; Drummond I; MacRae C; Pollak M
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):114-118. PubMed ID: 27509583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
